Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECALLANTIDE vs EFALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECALLANTIDE vs EFALIZUMAB: Safety Overview

Metric ECALLANTIDE EFALIZUMAB
Total FAERS Reports 1,206 230
Deaths Reported 23 73
Death Rate 1.9% 31.7%
Hospitalizations 499 44
Average Patient Age 42.9 yrs 52.3 yrs
% Female Patients 84.1% 46.2%
Manufacturer Takeda Pharmaceuticals America, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A